A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy
Public ClinicalTrials.gov record NCT00414908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assessed the effect of pancrelipase delayed release capsules on fat and nitrogen absorption in subjects with PEI due to Chronic Pancreatitis and Pancreatectomy. There was a run-in with a 5-day of single-blind placebo treatment, followed by a 7-day Double-blind period and a 6-month Open-Label Follow-up.
Study identification
- NCT ID
- NCT00414908
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 52 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- Aug 2008 (Actual)
- Completion
- Dec 2009 (Actual)
- Last update posted
- Aug 10, 2011
2007 – 2009
United States locations
- U.S. sites
- 23
- U.S. states
- 19
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 9 | Scottsdale | Arizona | — | — |
| Site 22 | Bristol | Connecticut | — | — |
| Site 7 | Tampa | Florida | — | — |
| Site 6 | Atlanta | Georgia | — | — |
| Site 17 | Chicago | Illinois | — | — |
| Site 30 | Maywood | Illinois | — | — |
| Site 14 | Indianapolis | Indiana | — | — |
| Site 15 | Kansas City | Kansas | — | — |
| Site 16 | Lexington | Kentucky | — | — |
| Site 12 | New Orleans | Louisiana | — | — |
| Site 3 | Boston | Massachusetts | — | — |
| Site 2 | Ann Arbor | Michigan | — | — |
| Site 29 | Grand Rapids | Michigan | — | — |
| Site 1 | Tupelo | Mississippi | — | — |
| Site 5 | St Louis | Missouri | — | — |
| Site 8 | Cedar Knolls | New Jersey | — | — |
| Site 20 | Boone | North Carolina | — | — |
| Site 4 | Rutherford College | North Carolina | — | — |
| Site 10 | Cincinnati | Ohio | — | — |
| Site 11 | Cleveland | Ohio | — | — |
| Site 21 | Pittsburgh | Pennsylvania | — | — |
| Site 13 | Dallas | Texas | — | — |
| Site 18 | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00414908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2011 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00414908 live on ClinicalTrials.gov.